Genome editing using designer nucleases promises to revolutionize modern medicine as it allows the direct correction of mutations causing devastating genetic disorders. However, safety concerns remain as a consequence of the unwanted modifications that arise from designer nucleases activity. I will discuss of our efforts in promoting seamless genome editing using modified CRISPR-based nucleases and alternative strategies that avoid the formation of a DNA double-stranded break for therapeutic purposes.
